Research
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity
Jacques Pépin, Louis Valiquette, Marie-Eve Alary, Philippe Villemure, Annick Pelletier, Karine Forget, Karine Pépin and Daniel Chouinard
CMAJ August 31, 2004 171 (5) 466-472; DOI: https://doi.org/10.1503/cmaj.1041104
Jacques Pépin
Louis Valiquette
Marie-Eve Alary
Philippe Villemure
Annick Pelletier
Karine Forget
Karine Pépin
Data supplements
Early Release
Files in this Data Supplement:
Related Articles
- (2004). Highlights of this issue. CMAJ, 171(5), 427. Accessed May 04, 2024. Retrieved from http://www.cmaj.ca/content/171/5/427.
In this issue
Article tools
Respond to this article
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity
Jacques Pépin, Louis Valiquette, Marie-Eve Alary, Philippe Villemure, Annick Pelletier, Karine Forget, Karine Pépin, Daniel Chouinard
CMAJ Aug 2004, 171 (5) 466-472; DOI: 10.1503/cmaj.1041104
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity
Jacques Pépin, Louis Valiquette, Marie-Eve Alary, Philippe Villemure, Annick Pelletier, Karine Forget, Karine Pépin, Daniel Chouinard
CMAJ Aug 2004, 171 (5) 466-472; DOI: 10.1503/cmaj.1041104
Jump to section
Related Articles
Cited By...
- Fecal Microbiota Transplantation Drives Colonic Expression of Immune Activation Genes in a Mouse Model of Antibiotic Use
- GRADING prognostic factors for severe and recurrent Clostridioides difficile infection: expected and unexpected findings. A systematic review
- Development and Validation of a web-based Postoperative Clostridioides difficile infection risk prediction model
- Management of difficult-to-treat Clostridioides difficile in a patient with chronic osteomyelitis
- Incidence and economic burden of Clostridioides difficile infection in Ontario: a retrospective population-based study
- Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
- Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
- Interspecies Interactions between Clostridium difficile and Candida albicans
- The Challenge of Clostridium difficile Infection
- Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole
- Temporal Changes in Serum Albumin and Total Protein in Patients with Hospital-acquired Clostridium difficile Infection
- The HtrA-Like Protease CD3284 Modulates Virulence of Clostridium difficile
- Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use
- Clostridium difficile Extracytoplasmic Function {sigma} Factor {sigma}V Regulates Lysozyme Resistance and Is Necessary for Pathogenesis in the Hamster Model of Infection
- Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile
- Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments
- Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
- Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain
- Proline-Dependent Regulation of Clostridium difficile Stickland Metabolism
- Inpatient diarrhoea and Clostridium difficile
- Intravenous immunoglobulin in treatment of Clostridium difficile colitis
- PrsW Is Required for Colonization, Resistance to Antimicrobial Peptides, and Expression of Extracytoplasmic Function {sigma} Factors in Clostridium difficile
- Modified Multiple-Locus Variable-Number Tandem-Repeat Analysis for Rapid Identification and Typing of Clostridium difficile during Institutional Outbreaks
- Is double coverage of gram-negative organisms necessary?
- The Changing Epidemiology of Clostridium difficile Infections
- Effects of Inoculum, pH, and Cations on the In Vitro Activity of Fidaxomicin (OPT-80, PAR-101) against Clostridium difficile
- In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas
- Multilocus Sequence Typing of Clostridium difficile
- Anti-Clostridium difficile Potential of Tetramic Acid Derivatives from Pseudomonas aeruginosa Quorum-Sensing Autoinducers
- Multilocus Variable-Number Tandem-Repeat Analysis and Multilocus Sequence Typing Reveal Genetic Relationships among Clostridium difficile Isolates Genotyped by Restriction Endonuclease Analysis
- Laboratory Markers as Predictors of Mortality in Patients With Clostridium difficile Infection
- Antiapoptotic Proteins Bcl-2 and Bcl-XL Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells
- Motility and Flagellar Glycosylation in Clostridium difficile
- Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile
- Recent advances in Clostridium difficile-associated disease
- Antimicrobial resistance in hospitals: How concerned should we be?
- Harbingers for Clostridium difficile-Associated Diarrhea
- Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection
- Genetic Relatedness of Clostridium difficile Isolates from Various Origins Determined by Triple-Locus Sequence Analysis Based on Toxin Regulatory Genes tcdC, tcdR, and cdtR
- Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006
- Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile
- Recent advances in Clostridium difficile-associated disease
- Current and future treatment modalities for Clostridium difficile-associated disease
- Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1
- Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters
- Use of Highly Discriminatory Fingerprinting to Analyze Clusters of Clostridium difficile Infection Cases Due to Epidemic Ribotype 027 Strains
- Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease
- Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphism, and Surface Layer Protein A Gene Sequence Typing
- Morphological and Genetic Diversity of Temperate Phages in Clostridium difficile
- Epidemiology of Clostridium difficile Associated Diarrhea in a Peruvian Tertiary Care Hospital
- Yield of Stool Culture with Isolate Toxin Testing versus a Two-Step Algorithm Including Stool Toxin Testing for Detection of Toxigenic Clostridium difficile
- Clostridium difficile Toxins A and B Directly Stimulate Human Mast Cells
- Clostridium difficile-associated diarrhoea: bovine anti-Clostridium difficile whey protein to help aid the prevention of relapses
- Typing and Subtyping of Clostridium difficile Isolates by Using Multiple-Locus Variable-Number Tandem-Repeat Analysis
- tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficile
- In Vitro Antianaerobic Activity of DX-619, a New Des-Fluoro(6)Quinolone
- In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada
- Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
- Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease?
- Multilocus Variable-Number Tandem-Repeat Analysis for Investigation of Clostridium difficile Transmission in Hospitals
- Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada
- Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates
- Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A
- Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
- How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?
- Clostridium difficile associated diarrhoea: diagnosis and treatment
- Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review
- Protecting against Clostridium difficile illness
- Strains and toxins of Clostridium
- Strains and toxins of Clostridium
- Les infections nosocomiales : que faut-il faire?
- Nosocomial infections: What needs to be done?